Effects of High-intensity Interval Training in Combination With Side-alternating Whole-body Vibration

NCT01875146 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2014-01-07

No results posted yet for this study

Summary

Investigation of the training effects following 8 weeks of high-intensity interval training (HIT)in combination with side-alternating whole-body vibration compared to conventional HIT or side-alternating whole-body vibration. The adaptations are investigated on a molecular (muscle biopsy of the M. vastus lateralis) and systemic (e.g. cycling, jumping mechanography, dynamometry) level. In addition, the acute effects of the first and last training session will be investigated on a molecular (e.g. satellite cell activation, mRNA abundance) and systemic (e.g. ventilatory ga exchange, heart rate, rating of perceived exertion) level.

Conditions

  • Health Behavior

Interventions

OTHER

4x4 min HIT

Conventional 4x4 min high-intensity interval training

OTHER

4x4 min HIT + WBV (18 Hz)

4x4 min high-intensity interval training in combination with whole-body vibration at 18 Hz during the active rest

OTHER

4x4 min HIT + (30 Hz)

4x4 min high-intensity interval training in combination with whole-body vibration at 30 Hz during the active rest

OTHER

whole-body vibration at 30 Hz

4x3 min whole-body vibration at 30 Hz

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Hans H Jung, Prof MD · University Hospital Zurich, Division of Neurology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01875146 on ClinicalTrials.gov